Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	N-acylphosphatidylethanolamine-specific phospholipase D activity	PLD1 PLD2	5.11e-05	3	83	2	GO:0070290
GeneOntologyMolecularFunction	structural constituent of nuclear pore	NUP98 NUP214 NUP54	1.49e-04	25	83	3	GO:0017056
GeneOntologyMolecularFunction	disaccharide binding	LGALS9C LGALS9B	3.54e-04	7	83	2	GO:0048030
GeneOntologyMolecularFunction	choline binding	CHAT CRP	3.54e-04	7	83	2	GO:0033265
GeneOntologyMolecularFunction	phospholipase D activity	PLD1 PLD2	4.70e-04	8	83	2	GO:0004630
GeneOntologyMolecularFunction	galactoside binding	LGALS9C LGALS9B	6.03e-04	9	83	2	GO:0016936
Domain	-	LGALS9C NPTX1 LGALS9B CNTNAP2 USH2A CRP	3.52e-06	95	81	6	2.60.120.200
Domain	PENTAXIN	NPTX1 ADGRD2 CRP	6.48e-06	9	81	3	PS00289
Domain	Pentaxin-related	NPTX1 ADGRD2 CRP	1.26e-05	11	81	3	IPR001759
Domain	Pentaxin	NPTX1 ADGRD2 CRP	1.26e-05	11	81	3	PF00354
Domain	PLipase_D1/D2	PLD1 PLD2	1.86e-05	2	81	2	IPR016555
Domain	PLipase_D_fam	PLD1 PLD2	1.86e-05	2	81	2	IPR015679
Domain	ConA-like_dom	LGALS9C NPTX1 LGALS9B CNTNAP2 ADGRD2 USH2A CRP	4.61e-05	219	81	7	IPR013320
Domain	PLDc_2	PLD1 PLD2	5.56e-05	3	81	2	PF13091
Domain	PLD-like_dom	PLD1 PLD2	5.56e-05	3	81	2	IPR025202
Domain	PLDc	PLD1 PLD2	1.11e-04	4	81	2	PF00614
Domain	YTH_domain	YTHDF2 YTHDF3	1.84e-04	5	81	2	IPR007275
Domain	-	FASN AASDH	1.84e-04	5	81	2	1.10.1200.10
Domain	PP-binding	FASN AASDH	1.84e-04	5	81	2	PF00550
Domain	Pentaxin_CS	NPTX1 CRP	1.84e-04	5	81	2	IPR030476
Domain	ACP_DOMAIN	FASN AASDH	1.84e-04	5	81	2	PS50075
Domain	YTH	YTHDF2 YTHDF3	1.84e-04	5	81	2	PS50882
Domain	YTH	YTHDF2 YTHDF3	1.84e-04	5	81	2	PF04146
Domain	PLDc	PLD1 PLD2	2.76e-04	6	81	2	SM00155
Domain	PP-bd_ACP	FASN AASDH	2.76e-04	6	81	2	IPR009081
Domain	PLipase_D/transphosphatidylase	PLD1 PLD2	3.85e-04	7	81	2	IPR001736
Domain	PLD	PLD1 PLD2	3.85e-04	7	81	2	PS50035
Domain	Sp1_fam	SP3 SP4	8.17e-04	10	81	2	IPR030450
Domain	PTX	NPTX1 CRP	8.17e-04	10	81	2	SM00159
Domain	FN3	SNED1 FLNC SPEG USH2A CDON	1.26e-03	185	81	5	SM00060
Domain	Gal-bind_lectin	LGALS9C LGALS9B	1.88e-03	15	81	2	PF00337
Domain	Gal-bind_lectin	LGALS9C LGALS9B	1.88e-03	15	81	2	SM00908
Domain	GALECTIN	LGALS9C LGALS9B	1.88e-03	15	81	2	PS51304
Domain	Galectin_CRD	LGALS9C LGALS9B	1.88e-03	15	81	2	IPR001079
Domain	GLECT	LGALS9C LGALS9B	1.88e-03	15	81	2	SM00276
Domain	FN3_dom	SNED1 FLNC SPEG USH2A CDON	2.15e-03	209	81	5	IPR003961
Domain	fn3	SNED1 SPEG USH2A CDON	5.41e-03	162	81	4	PF00041
Domain	AMP-binding	DIP2B AASDH	7.47e-03	30	81	2	PF00501
Domain	AMP-dep_Synth/Lig	DIP2B AASDH	7.47e-03	30	81	2	IPR000873
Pathway	REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN	NUP210 NUP98 NUP214 NUP54	9.12e-06	32	59	4	M29579
Pathway	REACTOME_EXPORT_OF_VIRAL_RIBONUCLEOPROTEINS_FROM_NUCLEUS	NUP210 NUP98 NUP214 NUP54	1.03e-05	33	59	4	M27016
Pathway	REACTOME_NUCLEAR_IMPORT_OF_REV_PROTEIN	NUP210 NUP98 NUP214 NUP54	1.17e-05	34	59	4	M27041
Pathway	REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS	NUP210 NUP98 NUP214 NUP54	1.32e-05	35	59	4	M27320
Pathway	REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA	NUP210 NUP98 NUP214 NUP54	1.47e-05	36	59	4	M26974
Pathway	REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY	NUP210 NUP98 NUP214 NUP54	1.47e-05	36	59	4	M27245
Pathway	REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS	NUP210 NUP98 NUP214 NUP54	1.65e-05	37	59	4	M1029
Pathway	REACTOME_INTERACTIONS_OF_REV_WITH_HOST_CELLULAR_PROTEINS	NUP210 NUP98 NUP214 NUP54	1.65e-05	37	59	4	M27038
Pathway	REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS	NUP210 NUP98 NUP214 NUP54	2.04e-05	39	59	4	M27238
Pathway	REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY	NUP210 NUP98 NUP214 NUP54	2.26e-05	40	59	4	MM14945
Pathway	REACTOME_NS1_MEDIATED_EFFECTS_ON_HOST_PATHWAYS	NUP210 NUP98 NUP214 NUP54	2.50e-05	41	59	4	M29574
Pathway	REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS	NUP210 NUP98 NUP214 NUP54	2.50e-05	41	59	4	MM15200
Pathway	REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS	NUP210 NUP98 NUP214 NUP54	2.75e-05	42	59	4	MM15039
Pathway	REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA	NUP210 NUP98 NUP214 NUP54	3.02e-05	43	59	4	MM14609
Pathway	REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS	NUP210 NUP98 NUP214 NUP54	3.02e-05	43	59	4	M26975
Pathway	REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS	NUP210 NUP98 NUP214 NUP54	3.32e-05	44	59	4	M109
Pathway	REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS	NUP210 NUP98 NUP214 NUP54	3.96e-05	46	59	4	M27397
Pathway	REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS	NUP210 NUP98 NUP214 AKT1S1 NUP54	4.02e-05	92	59	5	MM14951
Pathway	REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS	NUP210 NUP98 NUP214 NUP54	4.32e-05	47	59	4	M27395
Pathway	REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS	NUP210 NUP98 NUP214 NUP54	4.32e-05	47	59	4	MM14939
Pathway	REACTOME_GENE_SILENCING_BY_RNA	NUP210 NUP98 NUP214 NUP54	5.09e-05	49	59	4	MM14837
Pathway	REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS	NUP210 NUP98 NUP214 NUP54	5.52e-05	50	59	4	MM14610
Pathway	REACTOME_SLC_TRANSPORTER_DISORDERS	NUP210 SLC35A2 NUP98 NUP214 NUP54	5.72e-05	99	59	5	M27474
Pathway	REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS	NUP210 NUP98 NUP214 NUP54	5.97e-05	51	59	4	MM15151
Pathway	REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS	NUP210 NUP98 NUP214 AKT1S1 NUP54	6.30e-05	101	59	5	M27253
Pathway	REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN	NUP210 NUP98 NUP214 NUP54	6.95e-05	53	59	4	M27212
Pathway	REACTOME_SUMOYLATION	SP3 NUP210 NUP98 NR1H2 NUP214 NUP54	7.23e-05	169	59	6	MM14919
Pathway	REACTOME_SNRNP_ASSEMBLY	NUP210 NUP98 NUP214 NUP54	7.49e-05	54	59	4	M29594
Pathway	REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN	NUP210 NUP98 NUP214 NUP54	8.05e-05	55	59	4	MM14917
Pathway	REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS	NUP210 NUP98 NUP214 NUP54	9.92e-05	58	59	4	MM15149
Pathway	REACTOME_SNRNP_ASSEMBLY	NUP210 NUP98 NUP214 NUP54	9.92e-05	58	59	4	MM14736
Pathway	REACTOME_TRNA_PROCESSING_IN_THE_NUCLEUS	NUP210 NUP98 NUP214 NUP54	1.06e-04	59	59	4	M27606
Pathway	REACTOME_MITOTIC_PROPHASE	NUP210 NUP98 SMC4 NUP214 NUP54	1.12e-04	114	59	5	MM15361
Pathway	REACTOME_METABOLISM_OF_CARBOHYDRATES	ARSB GYG1 NUP210 NUP98 ST3GAL2 NUP214 NUP54	1.30e-04	271	59	7	MM15406
Pathway	REACTOME_SUMOYLATION	SP3 NUP210 NUP98 NR1H2 NUP214 NUP54	1.34e-04	189	59	6	M27214
Pathway	REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS	NUP210 NUP98 NUP214 NUP54	1.55e-04	65	59	4	MM15147
Pathway	REACTOME_METABOLISM_OF_CARBOHYDRATES	ARSB GYG1 NUP210 NUP98 ST3GAL2 NUP214 NUP54	1.90e-04	288	59	7	M16864
Pathway	PID_MTOR_4PATHWAY	ATG13 PLD1 PLD2 AKT1S1	1.95e-04	69	59	4	M121
Pathway	REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS	NUP210 NUP98 NUP214 FYN NUP54	2.15e-04	131	59	5	M5283
Pathway	REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS	NUP210 NUP98 NUP214 NUP54	2.18e-04	71	59	4	M27394
Pathway	REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE	NUP210 NUP98 NUP214 NUP54	2.43e-04	73	59	4	MM14948
Pathway	REACTOME_ISG15_ANTIVIRAL_MECHANISM	NUP210 NUP98 NUP214 NUP54	2.56e-04	74	59	4	M48006
Pathway	KEGG_MEDICUS_REFERENCE_NUCLEAR_EXPORT_OF_MRNA	NUP210 NUP214 NUP54	2.61e-04	30	59	3	M47752
Pathway	REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS	NUP210 NUP98 NUP214 NUP54	2.98e-04	77	59	4	M27226
Pathway	REACTOME_MITOTIC_PROPHASE	NUP210 NUP98 SMC4 NUP214 NUP54	3.13e-04	142	59	5	M27660
Pathway	PID_ALPHA_SYNUCLEIN_PATHWAY	PLD1 PLD2 FYN	3.17e-04	32	59	3	M275
Pathway	BIOCARTA_CB1R_PATHWAY	PLD1 PLD2	3.57e-04	7	59	2	MM1569
Pathway	BIOCARTA_CB1R_PATHWAY	PLD1 PLD2	3.57e-04	7	59	2	M22054
Pathway	REACTOME_GLUCOSE_METABOLISM	NUP210 NUP98 NUP214 NUP54	3.79e-04	82	59	4	MM15394
Pathway	REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE	NUP210 NUP98 NUP214 NUP54	3.79e-04	82	59	4	M27250
Pathway	REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS	NUP210 NUP98 NUP214 NUP54	4.16e-04	84	59	4	MM14929
Pathway	REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM	NUP210 NUP98 NUP214 NUP54	4.16e-04	84	59	4	M725
Pathway	REACTOME_GLUCOSE_METABOLISM	NUP210 NUP98 NUP214 NUP54	4.35e-04	85	59	4	M1870
Pathway	REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM	NUP210 NUP98 NUP214 NUP54	4.55e-04	86	59	4	MM15413
Pathway	REACTOME_SYNTHESIS_OF_PG	PLD1 PLD2	4.74e-04	8	59	2	M26961
Pathway	REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_LIPOGENESIS	FASN NR1H2	6.08e-04	9	59	2	M29789
Pathway	REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS	NUP210 SLC35A2 NUP98 NUP214 NUP54	8.53e-04	177	59	5	M27476
Pathway	BIOCARTA_NPC_PATHWAY	NUP210 NUP214	9.24e-04	11	59	2	M22033
Pathway	REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS	NUP210 NUP98 NUP214 NUP54	1.00e-03	106	59	4	M27458
Pathway	WP_PRADERWILLI_AND_ANGELMAN_SYNDROME	NUP210 NUP98 NUP214 NUP54	1.11e-03	109	59	4	M39542
Pathway	REACTOME_TRNA_PROCESSING	NUP210 NUP98 NUP214 NUP54	1.19e-03	111	59	4	M27684
Pathway	REACTOME_HCMV_LATE_EVENTS	NUP210 NUP98 NUP214 NUP54	1.40e-03	116	59	4	M29806
Pathway	PID_ARF6_DOWNSTREAM_PATHWAY	PLD1 PLD2	1.75e-03	15	59	2	M120
Pathway	REACTOME_PHOSPHOLIPID_METABOLISM	PLA1A FIG4 CHAT PLD1 PLD2	1.86e-03	211	59	5	M649
Pathway	REACTOME_SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES	NUP210 NUP98 NUP214 NUP54	1.89e-03	126	59	4	M45009
Pathway	KEGG_MEDICUS_REFERENCE_AUTOPHAGY_VESICLE_NUCLEATION_ELONGATION_MATURATION_MTORC1_PI3KC3_C1	ATG13 AKT1S1	1.99e-03	16	59	2	M47457
Pathway	REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS	PLA1A CHAT PLD1 PLD2	2.01e-03	128	59	4	M706
Pathway	REACTOME_HCMV_EARLY_EVENTS	NUP210 NUP98 NUP214 NUP54	2.64e-03	138	59	4	M29805
Pathway	REACTOME_GENE_SILENCING_BY_RNA	NUP210 NUP98 NUP214 NUP54	2.71e-03	139	59	4	M715
Pathway	REACTOME_HIV_INFECTION	NUP210 NUP98 NUP214 FYN NUP54	2.76e-03	231	59	5	M12469
Pathway	WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS	ITGAD CRP	2.81e-03	19	59	2	M39473
Pathway	WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX	FYN CRP	3.44e-03	21	59	2	M39876
Pathway	REACTOME_HIV_LIFE_CYCLE	NUP210 NUP98 NUP214 NUP54	3.48e-03	149	59	4	M4076
Pathway	REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES	NUP210 NUP98 NUP214 NUP54	3.65e-03	151	59	4	M550
Pathway	REACTOME_METABOLISM_OF_LIPIDS	FASN ARSB PLA1A FIG4 CHAT NR1H2 ST3GAL2 PLD1 PLD2	3.98e-03	757	59	9	M27451
Pubmed	A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.	NPTX1 ADAM9 DNAJC11 NUP210 NUP98 PKP2 ZYG11B NUP214 NUP54	4.16e-08	298	83	9	32353859
Pubmed	Transmodulation between phospholipase D and c-Src enhances cell proliferation.	PLD1 PLD2 FYN	2.61e-07	6	83	3	12697812
Pubmed	Nuclear import of hepatic glucokinase depends upon glucokinase regulatory protein, whereas export is due to a nuclear export signal sequence in glucokinase.	NUP210 NUP98 NUP214 NUP54	3.67e-07	25	83	4	10601273
Pubmed	Docking of HIV-1 Vpr to the nuclear envelope is mediated by the interaction with the nucleoporin hCG1.	NUP210 NUP98 NUP214 NUP54	4.33e-07	26	83	4	12228227
Pubmed	Cytoplasmic Metadherin (MTDH) provides survival advantage under conditions of stress by acting as RNA-binding protein.	FLNC FASN KMT2B FCGRT NUP210 PLD2 MTDH	8.46e-07	214	83	7	22199357
Pubmed	Peering through the pore: nuclear pore complex structure, assembly, and function.	NUP210 NUP98 NUP214 NUP54	2.09e-06	38	83	4	12791264
Pubmed	Phase-separated nuclear bodies of nucleoporin fusions promote condensation of MLL1/CRM1 and rearrangement of 3D genome structure.	NUP210 NUP98 NUP214 NUP54	2.58e-06	40	83	4	37516964
Pubmed	Genomic analysis of murine phospholipase D1 and comparison to phospholipase D2 reveals an unusual difference in gene size.	PLD1 PLD2	5.63e-06	2	83	2	9813240
Pubmed	Mono- and Poly-unsaturated Phosphatidic Acid Regulate Distinct Steps of Regulated Exocytosis in Neuroendocrine Cells.	PLD1 PLD2	5.63e-06	2	83	2	32814056
Pubmed	Functional analysis of mammalian phospholipase D enzymes.	PLD1 PLD2	5.63e-06	2	83	2	30369483
Pubmed	Differential regulation of apoptosis by caspase-mediated cleavage of phospholipase D isozymes.	PLD1 PLD2	5.63e-06	2	83	2	18694819
Pubmed	Increased phospholipase D activity contributes to tumorigenesis in prostate cancer cell models.	PLD1 PLD2	5.63e-06	2	83	2	32661773
Pubmed	Phospholipase D is involved in the formation of Golgi associated clathrin coated vesicles in human parotid duct cells.	PLD1 PLD2	5.63e-06	2	83	2	24618697
Pubmed	Phospholipase D is essential for keratocyte-like migration of NBT-II cells.	PLD1 PLD2	5.63e-06	2	83	2	18344600
Pubmed	Phospholipase D prevents apoptosis in v-Src-transformed rat fibroblasts and MDA-MB-231 breast cancer cells.	PLD1 PLD2	5.63e-06	2	83	2	12615079
Pubmed	Exosome Secretion and Epithelial-Mesenchymal Transition in Ovarian Cancer Are Regulated by Phospholipase D.	PLD1 PLD2	5.63e-06	2	83	2	36362078
Pubmed	Platelet derived growth factor increases phospholipase D1 but not phospholipase D2 expression via NFkappaB signaling pathway and enhances invasion of breast cancer cells.	PLD1 PLD2	5.63e-06	2	83	2	20188462
Pubmed	Organization and alternative splicing of the murine phospholipase D2 gene.	PLD1 PLD2	5.63e-06	2	83	2	9560313
Pubmed	Phospholipase D1 Ablation Disrupts Mouse Longitudinal Hippocampal Axis Organization and Functioning.	PLD1 PLD2	5.63e-06	2	83	2	32209478
Pubmed	Cross-talk between phospholipase D and MAP kinases activities.	PLD1 PLD2	5.63e-06	2	83	2	19896495
Pubmed	β-1,3-Glucan-induced host phospholipase D activation is involved in Aspergillus fumigatus internalization into type II human pneumocyte A549 cells.	PLD1 PLD2	5.63e-06	2	83	2	21760893
Pubmed	Pharmacological inhibition of phospholipase D protects mice from occlusive thrombus formation and ischemic stroke--brief report.	PLD1 PLD2	5.63e-06	2	83	2	23868933
Pubmed	Phospholipase D isoforms differentially regulate leukocyte responses to acute lung injury.	PLD1 PLD2	5.63e-06	2	83	2	29437245
Pubmed	Cloning and initial characterization of a human phospholipase D2 (hPLD2). ADP-ribosylation factor regulates hPLD2.	PLD1 PLD2	5.63e-06	2	83	2	9582313
Pubmed	PLD1 promotes reactive oxygen species production in vascular smooth muscle cells and injury-induced neointima formation.	PLD1 PLD2	5.63e-06	2	83	2	34610470
Pubmed	PLD1 and PLD2 differentially regulate the balance of macrophage polarization in inflammation and tissue injury.	PLD1 PLD2	5.63e-06	2	83	2	33368247
Pubmed	The phospholipase D pathway mediates the inflammatory response of the retinal pigment epithelium.	PLD1 PLD2	5.63e-06	2	83	2	25172550
Pubmed	Importance of PLD2 in an IL-23 driven psoriasiform dermatitis model and potential link to human psoriasis.	PLD1 PLD2	5.63e-06	2	83	2	37455419
Pubmed	Phospholipase D1 and D2 Synergistically Regulate Thrombus Formation.	PLD1 PLD2	5.63e-06	2	83	2	32971863
Pubmed	Involvement of Phospholipase D 1 and 2 in the subcellular localization and activity of formyl-peptide-receptors in the human colonic cell line HT29.	PLD1 PLD2	5.63e-06	2	83	2	19707939
Pubmed	Role of phospholipase D in bleomycin-induced mitochondrial reactive oxygen species generation, mitochondrial DNA damage, and pulmonary fibrosis.	PLD1 PLD2	5.63e-06	2	83	2	31090437
Pubmed	Phospholipase D in human platelets: presence of isoenzymes and participation of autocrine stimulation during thrombin activation.	PLD1 PLD2	5.63e-06	2	83	2	18432522
Pubmed	Phagocyte cell migration is mediated by phospholipases PLD1 and PLD2.	PLD1 PLD2	5.63e-06	2	83	2	16873675
Pubmed	Generation of choline for acetylcholine synthesis by phospholipase D isoforms.	PLD1 PLD2	5.63e-06	2	83	2	11734063
Pubmed	Deficiencies of the lipid-signaling enzymes phospholipase D1 and D2 alter cytoskeletal organization, macrophage phagocytosis, and cytokine-stimulated neutrophil recruitment.	PLD1 PLD2	5.63e-06	2	83	2	23383154
Pubmed	Characterization of human PLD2 and the analysis of PLD isoform splice variants.	PLD1 PLD2	5.63e-06	2	83	2	9761774
Pubmed	The molecular basis of leukocyte adhesion involving phosphatidic acid and phospholipase D.	PLD1 PLD2	5.63e-06	2	83	2	25187519
Pubmed	Phospholipase D in TCR-Mediated Signaling and T Cell Activation.	PLD1 PLD2	5.63e-06	2	83	2	29386256
Pubmed	Phospholipase D1 is a regulator of platelet-mediated inflammation.	PLD1 PLD2	5.63e-06	2	83	2	28711718
Pubmed	Positive feedback regulation between phospholipase D and Wnt signaling promotes Wnt-driven anchorage-independent growth of colorectal cancer cells.	PLD1 PLD2	5.63e-06	2	83	2	20711340
Pubmed	Key roles for the lipid signaling enzyme phospholipase d1 in the tumor microenvironment during tumor angiogenesis and metastasis.	PLD1 PLD2	5.63e-06	2	83	2	23131846
Pubmed	Phospholipase D: A new mediator during high phosphate-induced vascular calcification associated with chronic kidney disease.	PLD1 PLD2	5.63e-06	2	83	2	30207376
Pubmed	Redundant functions of phospholipases D1 and D2 in platelet α-granule release.	PLD1 PLD2	5.63e-06	2	83	2	22974101
Pubmed	Phospholipase D is a target for inhibition of astroglial proliferation by ethanol.	PLD1 PLD2	5.63e-06	2	83	2	24262632
Pubmed	The influence of polyunsaturated fatty acids on the phospholipase D isoforms trafficking and activity in mast cells.	PLD1 PLD2	5.63e-06	2	83	2	23698760
Pubmed	Phosphatidic acid, phospholipase D and tumorigenesis.	PLD1 PLD2	5.63e-06	2	83	2	24103483
Pubmed	Phospholipase D activates HIF-1-VEGF pathway via phosphatidic acid.	PLD1 PLD2	5.63e-06	2	83	2	25523098
Pubmed	YTHDF2/3 Are Required for Somatic Reprogramming through Different RNA Deadenylation Pathways.	YTHDF2 YTHDF3	5.63e-06	2	83	2	32905781
Pubmed	Phospholipase D messenger RNA expression and clinical role in high-grade serous carcinoma.	PLD1 PLD2	5.63e-06	2	83	2	28087476
Pubmed	Impaired brain development and reduced cognitive function in phospholipase D-deficient mice.	PLD1 PLD2	5.63e-06	2	83	2	24813107
Pubmed	Differential expression of phospholipases D1 and D2 in mouse tissues.	PLD1 PLD2	5.63e-06	2	83	2	17085061
Pubmed	Transcriptional repression of cyclin-dependent kinase inhibitor p21 gene by phospholipase D1 and D2.	PLD1 PLD2	5.63e-06	2	83	2	12782287
Pubmed	Structure and regulation of human phospholipase D.	PLD1 PLD2	5.63e-06	2	83	2	33495125
Pubmed	Phospholipases D1 and D2 Suppress Appetite and Protect against Overweight.	PLD1 PLD2	5.63e-06	2	83	2	27299737
Pubmed	Expression of MARCKS effector domain mutants alters phospholipase D activity and cytoskeletal morphology of SK-N-MC neuroblastoma cells.	PLD1 PLD2	5.63e-06	2	83	2	16341931
Pubmed	Phospholipase D in cell proliferation and cancer.	PLD1 PLD2	5.63e-06	2	83	2	14517341
Pubmed	Role of phospholipases D1 and 2 in astroglial proliferation: effects of specific inhibitors and genetic deletion.	PLD1 PLD2	5.63e-06	2	83	2	25967349
Pubmed	Cloning by recognition site screening of two novel GT box binding proteins: a family of Sp1 related genes.	SP3 SP4	5.63e-06	2	83	2	1454515
Pubmed	Increased expression of two phospholipase D isoforms during experimentally induced hippocampal mossy fiber outgrowth.	PLD1 PLD2	5.63e-06	2	83	2	14999815
Pubmed	Enzymatic Activity Is Not Required for Phospholipase D Mediated TNF-α Regulation and Myocardial Healing.	PLD1 PLD2	5.63e-06	2	83	2	30555342
Pubmed	Expression of phospholipase D isozymes in mouse lungs during postnatal development.	PLD1 PLD2	5.63e-06	2	83	2	19652486
Pubmed	Phospholipase D2, a distinct phospholipase D isoform with novel regulatory properties that provokes cytoskeletal reorganization.	PLD1 PLD2	5.63e-06	2	83	2	9395408
Pubmed	Phospholipase D and cancer metastasis: A focus on exosomes.	PLD1 PLD2	5.63e-06	2	83	2	36272918
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	FLNC FASN STARD9 DNAJC11 NUP98 SMC4 NIPSNAP2 ST3GAL2 OTUD3 CCDC57 TASOR MTDH SLC25A31 NUP54	7.56e-06	1442	83	14	35575683
Pubmed	Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.	NPTX1 ZNF609 ADAM9 DNAJC11 NUP210 NUP98 PKP2 ZYG11B NUP214 NUP54	1.26e-05	754	83	10	33060197
Pubmed	Galectin-9 is a high affinity IgE-binding lectin with anti-allergic effect by blocking IgE-antigen complex formation.	LGALS9C LGALS9B	1.69e-05	3	83	2	19776007
Pubmed	Galectin-9 regulates follicular helper T cells to inhibit humoral autoimmunity-induced pulmonary fibrosis.	LGALS9C LGALS9B	1.69e-05	3	83	2	33316546
Pubmed	Involvement of phospholipase D in regulating expression of anti-microbial peptide human beta-defensin-2.	PLD1 PLD2	1.69e-05	3	83	2	17986621
Pubmed	YTHDF2 suppresses the plasmablast genetic program and promotes germinal center formation.	YTHDF2 YTHDF3	1.69e-05	3	83	2	35508130
Pubmed	Identification and characterization of galectin-9, a novel beta-galactoside-binding mammalian lectin.	LGALS9C LGALS9B	1.69e-05	3	83	2	9038233
Pubmed	Protective effect of Galectin-9 in murine model of lung emphysema: Involvement of neutrophil migration and MMP-9 production.	LGALS9C LGALS9B	1.69e-05	3	83	2	28704475
Pubmed	A Unified Model for the Function of YTHDF Proteins in Regulating m6A-Modified mRNA.	YTHDF2 YTHDF3	1.69e-05	3	83	2	32492408
Pubmed	Transcriptional regulation of the mouse gene encoding the alpha-4 subunit of the GABAA receptor.	SP3 SP4	1.69e-05	3	83	2	15265862
Pubmed	Galectin-9 protein is up-regulated in astrocytes by tumor necrosis factor and promotes encephalitogenic T-cell apoptosis.	LGALS9C LGALS9B	1.69e-05	3	83	2	23836896
Pubmed	Sequence and mapping of galectin-5, a beta-galactoside-binding lectin, found in rat erythrocytes.	LGALS9C LGALS9B	1.69e-05	3	83	2	7890611
Pubmed	Galectin-9 suppresses Th17 cell development in an IL-2-dependent but Tim-3-independent manner.	LGALS9C LGALS9B	1.69e-05	3	83	2	22341088
Pubmed	Galectin-9 Is a Novel Regulator of Epithelial Restitution.	LGALS9C LGALS9B	1.69e-05	3	83	2	32380082
Pubmed	Galectin-9-mediated protection from allo-specific T cells as a mechanism of immune privilege of corneal allografts.	LGALS9C LGALS9B	1.69e-05	3	83	2	23667648
Pubmed	Regulatory T Cell-Mediated Suppression of Inflammation Induced by DR3 Signaling Is Dependent on Galectin-9.	LGALS9C LGALS9B	1.69e-05	3	83	2	28877989
Pubmed	Galectin-9 ameliorates immune complex-induced arthritis by regulating Fc gamma R expression on macrophages.	LGALS9C LGALS9B	1.69e-05	3	83	2	19800850
Pubmed	The effect of Toxoplasma gondii infection on galectin-9 expression in decidual macrophages contributing to dysfunction of decidual NK cells during pregnancy.	LGALS9C LGALS9B	1.69e-05	3	83	2	38987795
Pubmed	Complex phenotype of mice homozygous for a null mutation in the Sp4 transcription factor gene.	SP3 SP4	1.69e-05	3	83	2	11532028
Pubmed	Oncogenic miR-93-5p/Gal-9 axis drives CD8 (+) T-cell inactivation and is a therapeutic target for hepatocellular carcinoma immunotherapy.	LGALS9C LGALS9B	1.69e-05	3	83	2	37105392
Pubmed	m6A modification controls the innate immune response to infection by targeting type I interferons.	YTHDF2 YTHDF3	1.69e-05	3	83	2	30559377
Pubmed	Molecular mechanisms of N-formyl-methionyl-leucyl-phenylalanine-induced superoxide generation and degranulation in mouse neutrophils: phospholipase D is dispensable.	PLD1 PLD2	1.69e-05	3	83	2	23109426
Pubmed	Nucleoporins nup98 and nup214 participate in nuclear export of human immunodeficiency virus type 1 Rev.	NUP98 NUP214	1.69e-05	3	83	2	9847314
Pubmed	Galectin-9/Tim-3 pathway mediates dopaminergic neurodegeneration in MPTP-induced mouse model of Parkinson's disease.	LGALS9C LGALS9B	1.69e-05	3	83	2	36479526
Pubmed	Profiling Lgals9 splice variant expression at the fetal-maternal interface: implications in normal and pathological human pregnancy.	LGALS9C LGALS9B	1.69e-05	3	83	2	23242525
Pubmed	Galectin-9 in allergic airway inflammation and hyper-responsiveness in mice.	LGALS9C LGALS9B	1.69e-05	3	83	2	19851072
Pubmed	The Role of Galectin-9 as Mediator of Atopic Dermatitis: Effect on Keratinocytes.	LGALS9C LGALS9B	1.69e-05	3	83	2	33923930
Pubmed	Involvement of phospholipases D1 and D2 in sphingosine 1-phosphate-induced ERK (extracellular-signal-regulated kinase) activation and interleukin-8 secretion in human bronchial epithelial cells.	PLD1 PLD2	1.69e-05	3	83	2	12149127
Pubmed	Intracellular Galectin-9 Enhances Proximal TCR Signaling and Potentiates Autoimmune Diseases.	LGALS9C LGALS9B	1.69e-05	3	83	2	31969388
Pubmed	Obesity-induced galectin-9 is a therapeutic target in B-cell acute lymphoblastic leukemia.	LGALS9C LGALS9B	1.69e-05	3	83	2	35241678
Pubmed	Phospholipase D confers rapamycin resistance in human breast cancer cells.	PLD1 PLD2	1.69e-05	3	83	2	12813467
Pubmed	A role for nucleoporin FG repeat domains in export of human immunodeficiency virus type 1 Rev protein and RNA from the nucleus.	NUP98 NUP214	1.69e-05	3	83	2	8943370
Pubmed	Interaction of the type Ialpha PIPkinase with phospholipase D: a role for the local generation of phosphatidylinositol 4, 5-bisphosphate in the regulation of PLD2 activity.	PLD1 PLD2	1.69e-05	3	83	2	11032811
Pubmed	Possible regulatory role of galectin-9 on Ascaris suum-induced eosinophilic lung inflammation in mice.	LGALS9C LGALS9B	1.69e-05	3	83	2	22627368
Pubmed	Galectin-9 is required for endometrial regenerative cells to induce long-term cardiac allograft survival in mice.	LGALS9C LGALS9B	1.69e-05	3	83	2	33153471
Pubmed	m6A-binding YTHDF proteins promote stress granule formation.	YTHDF2 YTHDF3	1.69e-05	3	83	2	32451507
Pubmed	T cell immunoglobulin and mucin protein-3 (Tim-3)/Galectin-9 interaction regulates influenza A virus-specific humoral and CD8 T-cell responses.	LGALS9C LGALS9B	1.69e-05	3	83	2	22052881
GeneFamily	Nucleoporins	NUP210 NUP98 NUP214 NUP54	4.19e-06	32	62	4	1051
GeneFamily	Phospholipases	PLA1A PLD1 PLD2	4.01e-04	42	62	3	467
GeneFamily	Zinc fingers C2H2-type\|Sp transcription factors	SP3 SP4	4.10e-04	9	62	2	755
GeneFamily	Galectins	LGALS9C LGALS9B	1.18e-03	15	62	2	629
Coexpression	JAERVINEN_AMPLIFIED_IN_LARYNGEAL_CANCER	NPL KLHL7 DVL3 BRF2	7.46e-06	40	82	4	M4988
Coexpression	CAIRO_LIVER_DEVELOPMENT_DN	LGALS9C SP4 PLA1A LGALS9B BICRAL AQP1 CRP	1.02e-05	239	82	7	MM1274
Drug	Phe-gly	SP3 NUP210 NUP98 NUP214 NUP54	6.64e-06	73	82	5	CID000098207
Drug	Mianserine hydrochloride [21535-47-7]; Up 200; 13.2uM; MCF7; HT_HG-U133A	SNED1 HGF HIC2 SLC12A8 NUP214 UBOX5 CSTF2T	6.93e-06	196	82	7	6260_UP
Drug	U0125; Up 200; 1uM; PC3; HG-U133A	FCGRT ATG13 SPEG ABCB8 BICRAL PLD2 FYN	6.93e-06	196	82	7	663_UP
Drug	Pyrithyldione [77-04-3]; Up 200; 24uM; PC3; HT_HG-U133A	NUP210 SLC35A2 CNTNAP2 SLC12A8 NR1H2 FYN CDON	7.17e-06	197	82	7	7153_UP
Drug	Metformin hydrochloride [1115-70-4]; Up 200; 24.2uM; PC3; HT_HG-U133A	ZNF609 SPEG NUP210 CHAT ST3GAL2 CCDC57 UBOX5	7.41e-06	198	82	7	5068_UP
Drug	Trimethylcolchicinic acid [3482-37-9]; Down 200; 11.6uM; MCF7; HT_HG-U133A	ZNF609 EHBP1L1 NUP98 NIPSNAP2 ST3GAL2 PLD2 UBOX5	7.66e-06	199	82	7	2802_DN
Drug	Proparacaine hydrochloride [5875-06-9]; Down 200; 12uM; MCF7; HT_HG-U133A	ARSB SLC35A2 NUP98 SLC12A8 OTUD3 UBOX5 CDON	7.66e-06	199	82	7	6492_DN
Drug	2-(hydroxymethyl)-1,4-benzodioxan	PLD1 PLD2	3.84e-05	3	82	2	CID000019314
Drug	sialylphospholipid	PLD1 PLD2	3.84e-05	3	82	2	CID000515706
Drug	Metoclopramide monohydrochloride [7232-21-5]; Down 200; 11.8uM; PC3; HT_HG-U133A	FASN TRAF4 CNTNAP2 BICRAL FYN UBOX5	7.04e-05	193	82	6	4285_DN
Drug	splitomicin; Up 200; 20uM; PC3; HG-U133A	TRAF4 NPTX1 ZNF609 FCGRT ATG13 SPEG	7.24e-05	194	82	6	661_UP
Drug	Hydroxyzine dihydrochloride [2192-20-3]; Down 200; 9uM; PC3; HT_HG-U133A	ARSB PLA1A NUP214 FYN CSTF2T CDON	7.24e-05	194	82	6	6660_DN
Drug	Estrone [53-16-7]; Down 200; 14.8uM; PC3; HT_HG-U133A	TRAF4 ZNF609 PLA1A SLC12A8 NR1H2 CSTF2T	7.24e-05	194	82	6	6647_DN
Drug	Fluphenazine dihydrochloride [146-56-5]; Down 200; 7.8uM; MCF7; HT_HG-U133A	ZNF609 ATG13 SMC4 HIC2 OTUD3 PLD2	7.24e-05	194	82	6	3194_DN
Drug	(-)-Isoproterenol hydrochloride [5984-95-2]; Up 200; 16.2uM; MCF7; HT_HG-U133A	EHBP1L1 SPEG CHAT SLC12A8 CCDC57 CDON	7.24e-05	194	82	6	6833_UP
Drug	Famotidine [76824-35-6]; Up 200; 11.8uM; PC3; HG-U133A	ZNF609 NUP98 ST3GAL2 PLD1 UBOX5 TASOR	7.45e-05	195	82	6	1946_UP
Drug	Froxiprostum	PLD1 PLD2	7.65e-05	4	82	2	CID006434698
Drug	Ioxaglic acid [59017-64-0]; Down 200; 3.2uM; MCF7; HT_HG-U133A	ZNF609 KMT2B SLC35A2 NUP214 CSTF2T BRF2	7.67e-05	196	82	6	7470_DN
Drug	Sulindac [38194-50-2]; Down 200; 11.2uM; HL60; HT_HG-U133A	HGF TTBK2 ATG13 SLC35A2 MTDH CSTF2T	7.67e-05	196	82	6	1857_DN
Drug	Dinoprost trometamol [38362-01-5]; Down 200; 8.4uM; MCF7; HT_HG-U133A	TRAF4 ZNF609 DVL3 HIC2 PLD2 UBOX5	7.67e-05	196	82	6	5409_DN
Drug	Nifenazone [2139-47-1]; Down 200; 13uM; MCF7; HT_HG-U133A	TRAF4 BICRAL OTUD3 UBOX5 CSTF2T BRF2	7.89e-05	197	82	6	2285_DN
Drug	Flufenamic acid [530-78-9]; Down 200; 14.2uM; MCF7; HT_HG-U133A	ZNF609 SLC35A2 DVL3 NUP214 UBOX5 CSTF2T	7.89e-05	197	82	6	2267_DN
Drug	Harmalol hydrochloride dihydrate [6028-07-5]; Down 200; 14.6uM; MCF7; HT_HG-U133A	TTBK2 EHBP1L1 SMC4 SLC12A8 PLD2 UBOX5	7.89e-05	197	82	6	2892_DN
Drug	Ethotoin [86-35-1]; Up 200; 19.6uM; PC3; HT_HG-U133A	TRAF4 DVL3 PLD1 CCDC102B CSTF2T CDON	7.89e-05	197	82	6	4545_UP
Drug	2-propylpentanoic acid; Down 200; 500uM; HL60; HT_HG-U133A	FASN EHBP1L1 KMT2B NUP210 NUP98 HIC2	7.89e-05	197	82	6	1181_DN
Drug	rottlerin; Down 200; 10uM; MCF7; HT_HG-U133A_EA	ZNF609 NUP98 DVL3 NR1H2 ST3GAL2 CSTF2T	8.11e-05	198	82	6	914_DN
Drug	Gabapentin [60142-96-3]; Down 200; 23.4uM; MCF7; HT_HG-U133A	TRAF4 ARSB KMT2B SLC12A8 NUP214 UBOX5	8.11e-05	198	82	6	3472_DN
Drug	Epicatechin-(-) [154-23-4]; Up 200; 13.8uM; PC3; HT_HG-U133A	SNED1 NPTX1 MYOZ1 SLC6A16 HIC2 PLD1	8.11e-05	198	82	6	4594_UP
Drug	Oleandomycin phosphate [7060-74-4]; Down 200; 5uM; PC3; HT_HG-U133A	TRAF4 ZNF609 NUP210 SLC35A2 PLD2 BRF2	8.34e-05	199	82	6	4615_DN
Drug	(+/-)-thalidomide; Up 200; 100uM; MCF7; HG-U133A	HGF SP4 ZNF609 KCNQ4 AQP1 CRP	8.34e-05	199	82	6	606_UP
Drug	Norcyclobenzaprine [303-50-4]; Up 200; 15.4uM; HL60; HT_HG-U133A	FLNC TRAF4 NPTX1 MYOZ1 CNTNAP2 SLC12A8	8.34e-05	199	82	6	2469_UP
Drug	2-propylpentanoic acid; Down 200; 1000uM; MCF7; HT_HG-U133A	ATG13 NUP210 SLC35A2 BICRAL OTUD3 BRF2	8.34e-05	199	82	6	6969_DN
Drug	Tiletamine hydrochloride; Up 200; 15.4uM; HL60; HT_HG-U133A	SP4 ARSB HIC2 PLD2 CCDC57 CDON	8.34e-05	199	82	6	3137_UP
Drug	Metixene hydrochloride [1553-34-0]; Down 200; 11.6uM; PC3; HT_HG-U133A	ZNF609 NUP210 ST3GAL2 PLD1 PLD2 UBOX5	8.34e-05	199	82	6	6672_DN
Drug	Nimodipine [66085-59-4]; Down 200; 9.6uM; MCF7; HT_HG-U133A	NPTX1 ZNF609 NUP98 OTUD3 PLD2 CSTF2T	8.34e-05	199	82	6	6480_DN
Drug	FK-506; Down 200; 1uM; MCF7; HG-U133A	ZNF609 KLHL7 CNTNAP2 ST3GAL2 NUP214 PGC	8.34e-05	199	82	6	284_DN
Drug	Chlorpheniramine maleate [113-92-8]; Up 200; 10.2uM; MCF7; HT_HG-U133A	SNED1 EHBP1L1 PKP2 CHAT PLD1 UBOX5	8.34e-05	199	82	6	6773_UP
Drug	Urosiol [128-13-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A	TRAF4 NUP98 SLC12A8 PLD2 UBOX5 BRF2	8.57e-05	200	82	6	6484_DN
Drug	Carbamazepine [298-46-4]; Up 200; 17uM; MCF7; HT_HG-U133A	ARSB MYOZ1 UBOX5 CSTF2T CDON BRF2	8.57e-05	200	82	6	1683_UP
Drug	poly(tetramethylene adipate	SP3 SP4	1.27e-04	5	82	2	CID000032794
Drug	Phosphorylcholine	FASN CRP	1.27e-04	5	82	2	ctd:D010767
Disease	developmental cardiac valvular defect (implicated_via_orthology)	PLD1 PLD2	6.90e-06	2	78	2	DOID:0080633 (implicated_via_orthology)
Disease	Pituitary stalk interruption syndrome	LHX4 CDON	1.44e-04	7	78	2	C4053775
Disease	obsolete_red blood cell distribution width	DIP2B SP3 EHBP1L1 KCNA4 KMT2B FIG4 NUP210 ADGRD2 PLD1 ITGAD PGC MTDH	2.08e-04	1347	78	12	EFO_0005192
Disease	dystonia (is_implicated_in)	KMT2B NUP54	6.15e-04	14	78	2	DOID:543 (is_implicated_in)
Disease	autosomal dominant intellectual developmental disorder (is_implicated_in)	DIP2B KMT2B	9.14e-04	17	78	2	DOID:0060307 (is_implicated_in)
Disease	alpha-tocopherol measurement	HGF USH2A	1.27e-03	20	78	2	EFO_0007898
Disease	disease of metabolism (implicated_via_orthology)	YTHDF2 YTHDF3	1.40e-03	21	78	2	DOID:0014667 (implicated_via_orthology)
Disease	chronic widespread pain	DIP2B CDON	1.68e-03	23	78	2	EFO_0010099
Disease	Reperfusion Injury	HGF CHAT AKT1S1	1.71e-03	89	78	3	C0035126
Disease	Liver carcinoma	HGF FASN KMT2B NR1H2 YTHDF2 CRP	2.26e-03	507	78	6	C2239176
Disease	status epilepticus (biomarker_via_orthology)	ADAM9 AQP1 CRP	2.39e-03	100	78	3	DOID:1824 (biomarker_via_orthology)
Disease	hemoglobin A1 measurement	KCNA4 SLC12A8 ZYG11B PLD1 ITGAD YTHDF2	2.56e-03	520	78	6	EFO_0007629

Protein segments in the cluster

Peptide	Gene	Start	Entry
ELGQSQAGGESGSGQ	ADGRF3	96	Q8IZF5
SGEQLGISDNGGLFV	AKT1S1	116	Q96B36
FGEVQLSGLGEGFQT	ATG13	156	O75143
NGIVRGAGYNVGQSV	CSMD2	2131	Q7Z408
DGVNSGQGLGIEIIG	AQP1	131	P29972
GFTIQEGSGQVFLGG	AASDH	391	Q4L235
GISIVGQSNERGDGG	DVL3	261	Q92997
GNEAVGGFFSQIGQL	NIPSNAP2	216	O75323
GVLVLGQEQDTLGGG	NPTX1	351	Q15818
GLVQGLAIGNGTVSG	NUP210	1126	Q8TEM1
VINQTGGYSDGLGGN	PBX3	381	P40426
TQNGNGGGSINFALR	DNAJC11	186	Q9NVH1
GTGLFGQTNTGFGAV	NUP98	346	P52948
IQGGLQDGFQITVNG	LGALS9C	21	Q6DKI2
IQGGLQDGFQITVNG	LGALS9B	21	Q3B8N2
LTAVQSEQGEAGGGG	KCNQ4	26	P56696
LRNGLAAGTGQGDFG	FCGRT	236	P55899
GQEQAFSVNTRGAGG	FLNC	981	Q14315
FSVNTRGAGGQGQLD	FLNC	986	Q14315
AGGQQIGFLLGSCGI	DIP2B	441	Q9P265
LQLVQLEGGGGAGTY	EHBP1L1	1146	Q8N3D4
FGQAASTGGIVFGQQ	NUP214	1851	P35658
NRIYGNVGDVTGGQL	LHX4	271	Q969G2
MGQLSLGLESGQGQG	KMT2B	316	Q9UMN6
VGGQNGLGGLDNVEY	KLHL7	486	Q8IXQ5
IQGQGEGYRGTVNTI	HGF	306	P14210
GGSGARIFGNQGLNE	OTUD3	301	Q5T2D3
DAGGFGQSVVQFGGS	ITGAD	31	Q13349
LGTGLGFGGFNTQQQ	NUP54	81	Q7Z3B4
GIAGLYQGFGVSVQG	SLC25A31	181	Q9H0C2
GGQAGGAQQGFLLRD	CMPK2	121	Q5EBM0
QGSFDGGDQGILNTF	GYG1	156	P46976
QISGSGQIQLIGSFG	BICRAL	206	Q6AI39
DEGLITQGGSGVFGI	FIG4	206	Q92562
AGGQGLTVFGGVNSS	FYN	56	P06241
VGQTGQRGRQGDSGI	COL6A5	1641	A8TX70
SQINGNVHGGFLTNG	CDON	1026	Q4KMG0
AVNGIVNGSLNGGLY	CDON	1056	Q4KMG0
GGNFEGSQSLVGDIG	CRP	161	P02741
TNGNLINIVGGAGDV	ADAM9	266	Q13443
AGGSVQAGQAGGSVQ	CCDC57	636	Q2TAC2
QGQGEGEVGNNSLGL	BRF2	331	Q9HAW0
VSSGLNENLTVNGGG	MTDH	271	Q86UE4
IFSTDNGGQTLAGGN	ARSB	296	P15848
QLFVGGAGGQQGFLG	CNTNAP2	921	Q9UHC6
TGIQGTGMQGAGIQG	CSTF2T	511	Q9H0L4
LVQGTQGFSGGELGQ	FIGNL2	586	A6NMB9
GNVGINSFGFGGSNV	FASN	386	P49327
GRATGITGNFANIGG	SLC22A25	466	Q6T423
GQTGGTIGLLYVFGQ	SLC12A8	116	A0AV02
LDGVDLFNNGGSGNG	CCDC102B	221	Q68D86
IGGSLVAGQQLTGGD	ABCB8	396	Q9NUT2
LFLGGSNQDSVQGLG	HIC2	201	Q96JB3
QGVKNIFVNGTTGEG	NPL	41	Q9BXD5
VNGEGGSGGNSRQLQ	RSBN1L	56	Q6PCB5
GQGSGLGGQLSEVSG	SYNPO2L	371	Q9H987
GSTVIGDNTGVFLGG	USH2A	1636	O75445
INIDLTAGGGQNVTG	UBOX5	66	O94941
INNVAAGGGTGQVGQ	SP4	271	Q02446
LAGGQVLSNTGIGLG	SLC6A16	341	Q9GZN6
GFEGDISTGGGNALQ	PLD1	826	Q13393
AGSQGSGEGEGVQLT	NR1H2	206	P55055
GNSGNLRGSGYGQDV	ST3GAL2	156	Q16842
RDQASGGGEGFAQGV	STARD9	3216	Q9P2P6
FTGVAIVQAQQAGGG	SLC35A2	176	P78381
TGLGGIAAQAGFNAG	SNED1	206	Q8TER0
SSQQNGGGGGLNIAE	TASOR	36	Q9UK61
GGILVLGQDQDSLGG	ADGRD2	246	Q7Z7M1
VQQFGAPGGLGETLQ	CHAT	166	P28329
GQLFGGQLGQITGLD	PLA1A	176	Q53H76
QNNGAGSENFGLGVV	YTHDF3	366	Q7Z739
GLLNDGTVGIFRGNQ	ZYG11B	66	Q9C0D3
QEGFGEGQGLQAAGT	UBTFL6	341	P0CB48
NQQGSSGGAVVFGGV	PGC	216	P20142
GQTVLEQEAGSGGGT	SPEG	191	Q15772
GQQVQIGFTGSSDNG	SP3	181	Q02447
QADGGGSNGFIAVNL	TTBK2	526	Q6IQ55
VQGRSGDGANAGGLV	ZNF609	121	O15014
QGQIIEQSGTMTGGG	SMC4	741	Q9NTJ3
LQVSAFLNGNGSGEG	TRAF4	346	Q9BUZ4
GFEGDISTGGGNSIQ	PLD2	686	O14939
VGQAAAGGSGNLLTE	PKP2	321	Q99959
FGHNGVDGNGVGQSQ	YTHDF2	361	Q9Y5A9
FITLGTDLAQQQGGG	KCNA4	416	P22459
ELTGGGQESSGLNLG	MYOZ1	21	Q9NP98